Cargando…
Lowering the risk of gout: Another benefits from the use of sodium–glucose cotransporter 2 inhibitors
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7477493/ https://www.ncbi.nlm.nih.gov/pubmed/32190971 http://dx.doi.org/10.1111/jdi.13254 |